Sfoglia per AUTORE
LIN J
Collezione AOU San Luigi di Orbassano
Items : 2
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042. in JTO clinical and research reports / JTO Clin Res Rep. 2021 Jul 1;2(8):100205. doi: 10.1016/j.jtocrr.2021.100205. eCollection 2021 Aug.
2021
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Mansfield AS; Herbst RS; de Castro G Jr; Hui R; Peled N; Kim DW; Novello S; Satouchi M; Wu YL; Garon EB; Reck M; Robinson AG; Samkari A; Piperdi B; Ebiana V; Lin J; Mok TSK;
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer. in Investigational new drugs / Invest New Drugs. 2016 Oct;34(5):625-35. doi: 10.1007/s10637-016-0368-1. Epub 2016 Jun 27.
2016
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Scagliotti G; Kang JH; Smith D; Rosenberg R; Park K; Kim SW; Su WC; Boyd TE; Richards DA; Novello S; Hynes SM; Myrand SP; Lin J; Smyth EN; Wijayawardana S; Lin AB; Pinder-Schenck M;